当前位置:首页 - 行情中心 - 海王生物(000078) - 财务分析 - 现金流量表

海王生物

(000078)

  

流通市值:61.19亿  总市值:64.09亿
流通股本:26.26亿   总股本:27.51亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金8,348,547,159.9138,320,966,241.0128,313,286,615.2219,437,445,893.66
收到的税费返还286,437.798,512,692.159,580,729.437,518,503.4
收到其他与经营活动有关的现金1,062,598,361.272,768,148,062.822,208,618,592.371,368,561,287.16
经营活动现金流入的平衡项目0000
经营活动现金流入小计9,411,431,958.9741,097,626,995.9830,531,485,937.0220,813,525,684.22
购买商品、接受劳务支付的现金7,390,070,465.2834,288,472,310.725,255,847,361.5717,219,998,817.82
支付给职工以及为职工支付的现金268,806,252.281,087,026,609.31785,343,099.19518,158,362.03
支付的各项税费183,747,928.79913,561,269.49740,566,174.59527,295,230.57
支付其他与经营活动有关的现金1,512,051,827.315,218,756,094.283,574,881,154.92,331,596,746.15
经营活动现金流出的平衡项目0000
经营活动现金流出小计9,354,676,473.6641,507,816,283.7830,356,637,790.2520,597,049,156.57
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额56,755,485.31-410,189,287.8174,848,146.77216,476,527.65
二、投资活动产生的现金流量:
收回投资收到的现金95,084,000786,444,996.7840,641,106.3820,655,526.13
取得投资收益收到的现金3,896,375.095,107,915.441,460,515.841,146,310.9
处置固定资产、无形资产和其他长期资产收回的现金净额2,758,815.733,054,664.135,671,655.831,780,258.91
处置子公司及其他营业单位收到的现金净额4,644,810.96495,240.043,632,300.37-
收到的其他与投资活动有关的现金-529,100--
投资活动现金流入的平衡项目0000
投资活动现金流入小计106,384,001.78795,631,916.3951,405,578.4223,582,095.94
购建固定资产、无形资产和其他长期资产支付的现金24,823,369.61104,074,606.2875,060,494.6851,314,248.72
投资支付的现金96,091,000749,860,579.757,317,739.256,317,739.25
取得子公司及其他营业单位支付的现金18,653,540.7182,010,183.6382,808,677.5262,067,774.89
支付其他与投资活动有关的现金-111,239.86170,000,000160,012,510.59
投资活动现金流出的平衡项目0000
投资活动现金流出小计139,567,910.32936,056,609.52335,186,911.45279,712,273.45
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-33,183,908.54-140,424,693.13-283,781,333.03-256,130,177.51
三、筹资活动产生的现金流量:
吸收投资收到的现金-744,444529,100529,100
其中:子公司吸收少数股东投资收到的现金-744,444529,100529,100
取得借款收到的现金2,829,537,325.8411,040,351,098.4413,301,995,964.067,744,746,560.93
收到其他与筹资活动有关的现金1,892,771,414.018,284,107,712.744,588,077,747.963,782,362,784.62
筹资活动现金流入平衡项目0000
筹资活动现金流入小计4,722,308,739.8519,325,203,255.1817,890,602,812.0211,527,638,445.55
偿还债务支付的现金3,067,712,230.1410,807,848,529.6912,963,750,718.817,133,747,400.45
分配股利、利润或偿付利息支付的现金181,437,649.5691,228,470.83494,647,500.64380,273,049.72
其中:子公司支付给少数股东的股利、利润42,621,412.32137,394,339.1286,668,847.5362,567,596.87
支付其他与筹资活动有关的现金1,531,010,273.147,101,284,545.314,563,231,318.854,031,010,044.12
筹资活动现金流出平衡项目0000
筹资活动现金流出小计4,780,160,152.7818,600,361,545.8318,021,629,538.311,545,030,494.29
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-57,851,412.93724,841,709.35-131,026,726.28-17,392,048.74
四、汇率变动对现金及现金等价物的影响--2,011.522,013.62
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-34,279,836.16174,227,728.42-239,957,901.02-57,043,684.98
加:期初现金及现金等价物余额1,136,730,048.28962,502,319.86962,502,319.86962,502,319.86
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,102,450,212.121,136,730,048.28722,544,418.84905,458,634.88
补充资料:
净利润--1,719,032,856.32-163,977,562.12
资产减值准备-1,385,520,950.23-21,898,572.31
固定资产和投资性房地产折旧-156,681,984.29-71,556,348.6
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-156,681,984.29-71,556,348.6
无形资产摊销-41,142,904.55-18,776,713.53
长期待摊费用摊销-18,319,192.27-13,568,937.84
处置固定资产、无形资产和其他长期资产的损失--3,237,874.71--544,973.44
公允价值变动损失--17,752,259.55--425,930.5
财务费用-945,944,671.94-430,468,506.4
投资损失-45,417,836.01--24,393,439.49
递延所得税-86,708,407.26-2,303,268.35
其中:递延所得税资产减少-88,512,432-2,980,368.95
递延所得税负债增加--1,804,024.74--677,100.6
存货的减少-478,597,867.92-498,649,880
经营性应收项目的减少--584,560,779.53--631,114,390.17
经营性应付项目的增加--1,330,027,589.93--384,938,255.95
融资租入固定资产-98,937,429.13--
现金的期末余额-1,136,730,048.28--
减:现金的期初余额-962,502,319.86--
加:现金等价物的期末余额---905,458,634.88
减:现金等价物的期初余额---962,502,319.86
公告日期2024-04-302024-04-302023-10-302023-08-29
审计意见(境内)标准无保留意见
TOP↑